- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07677657
Deepview HHF Training and Validation Study (UK HHF)
June 24, 2026 updated by: SpectralMD
Deepview HHF Training and Validation Label Expansion Study
The purpose of this Study is to help expand the use of the DeepView AI System so that it can assess burn injuries on the hands, head/face, and feet.
To do this, the Study will collect new images of burns in these areas.
Some of these images will be used to improve and retrain the AI system, while others will be used to test how well the updated system performs.
The images for both purposes will be collected at the same time.
The new images from the hands, head/face, and feet will then be combined with existing images from other body areas.
This will allow researchers to determine whether the updated AI system performs as well as, or better than, previous versions of the technology.
For participants with Study Burns requiring surgical excision, the Study site clinician will collect punch biopsies from the Study Burn according to a standardised burn wound punch biopsy collection.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
280
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Alexandra Krajcevska, MTM
- Phone Number: 972-499-4934
- Email: krajcevska@spectralmd.com
Study Contact Backup
- Name: Taylor Frank
- Email: frank@spectralmd.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Subjects enrolled in this study will be recruited at the designated Study Site within 72 hours of suffering a thermal burn injury.
Adult and pediatric Subjects with burns from one or more of the defined burn severities will be enrolled.
All Subjects must meet the specified inclusion criteria.
Description
Inclusion Criteria:
- Willing and able to give informed consent, have a witnessed verbal consent, family discussion if intubated and retrospective consent for those that are intubated
- Life expectancy > 1 month
- Thermal burn mechanism (flame, scald, or contact)
- The Study Burn(s) occurred less than 72 hours prior to the time of first imaging
- Minimum burn wound size for adult or paediatric participants is 0.25% TBSA per region
- Have burn(s) on the head, hands and/or feet that meet the criteria for a Study Burn. If multiple regions meet the Study Burn criteria, per the discretion of the Investigator, all Study Burn regions should be included.
Exclusion Criteria:
- Sepsis at the time of enrolment
- Infection of the burn wound at the time of enrolment
- Immunosuppression / radiation / chemotherapy < 3 months prior to enrolment
- Concurrent use of investigational products with a known effect on the burn sites; and/or imaging
- Concurrent use of products such as chemical debriding agents, skin substitutes and others that the principal investigator deems will have an impact on the image quality and healing potential of a Study Burn
- Any condition that, in the opinion of the Investigator, may prevent compliance with the study requirements or compromise Participant safety
- Participants without a burn on the hands, feet, head or neck, or burns located on these regions only on the palmar or plantar surfaces
- Chemical or any other non-thermal burns
8. Participants anticipated to or undergoing enzymatic debridemen9
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Subjects with Thermal Burn Injury
An initial imaging with the DV-SSP would be completed at the Study Site within 72 hours of suffering a thermal burn injury.
|
DeepView is an assistive imaging device which will be used to collect observational data as part of the study.
The device will be blinded and only used for data collection.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Label Expansion Through Imaging HHF
Time Frame: Time of Injury through 21 Day Healing Assessment
|
The number of Hand, Head, Feet (HHF) images collected with the DeepView AI System (DV) is the primary objective of this study in order to support the expansion of the intended use of the DV System.
These images are used to assess the ground truth using a panel of expert burn surgeons.
|
Time of Injury through 21 Day Healing Assessment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
April 1, 2027
Study Completion (Estimated)
May 1, 2027
Study Registration Dates
First Submitted
June 18, 2026
First Submitted That Met QC Criteria
June 24, 2026
First Posted (Actual)
July 1, 2026
Study Record Updates
Last Update Posted (Actual)
July 1, 2026
Last Update Submitted That Met QC Criteria
June 24, 2026
Last Verified
June 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CLA-PR-12
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Burns
-
Fondation Ophtalmologique Adolphe de RothschildNot yet recruiting
-
American Scitech InternationalJohnson & JohnsonUnknownBurns | Electric BurnsUnited States
-
MediWound LtdUnknownBurns, Upper Extremity | Burns, Lower ExtremitySlovakia
-
Singapore General HospitalUnknownAcute Thermal BurnsSingapore
-
RenovaCare, IncActive, not recruitingBurns | Burns Second Degree | Burns Deep Second DegreeUnited States
-
Sun Yat-sen UniversityCompleted
-
Hennepin Healthcare Research InstituteNot yet recruiting
-
Buckinghamshire Healthcare NHS TrustNot yet recruitingBurns Multiple
-
Virginia Commonwealth UniversityWithdrawn
-
Riphah International UniversityActive, not recruiting
Clinical Trials on DeepView AI System
-
SpectralMDBaylor Research InstituteTerminatedPeripheral Arterial Disease | Amputation WoundUnited States
-
SpectralMDCompleted
-
SpectralMDCompleted
-
Magic Health Inc. (d.b.a. Nolla Health)RecruitingDifferential Diagnosis | Diagnostic AccuracyUnited States
-
Tsinghua UniversityNot yet recruiting
-
The Third Xiangya Hospital of Central South UniversityRecruitingMediastinum DiseaseChina
-
Qun ZhaoCompletedGastrointestinal Stromal Tumors | Gastric Subepithelial Tumors | Artificial Intelligence (AI) | Gastric Leiomyoma | Multimodal ImagingChina
-
The Hong Kong Polytechnic UniversityNot yet recruitingRetinal Disease | Eye Disease | Ophthalmology | AI Agent | Large Language ModelsChina
-
Qilu Hospital of Shandong UniversityThe Affiliated Hospital of Qingdao University; Shandong Provincial Hospital; Liaocheng... and other collaboratorsRecruitingThe Malignant Lesions and Non-malignant Lesions of Pancreas, Bile Duct, Liver and Lymph NodeChina